CRISPRi
Aug 14, 2024
A CRISPRi Screen to Identify RNA Binding Proteins With Oncogenic Functions in Colorectal Cancer
A CRISPRi screen in colorectal cancer cells identified RBPs (PELO, RBM22, ZMAT2) that promote proliferation and are essential for survival. Ongoing research aims to validate knockdown results and examine gene regulatory mechanisms, with potential for future therapeutic interventions.
Aug 14, 2024
CRISPRi
Aug 14, 2024